discovery

1:22-cv-10313 United States of America et al v. LabQ Clinical Diagnostics, LLC et al

22-cv-10313 Filed
Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

United States of America et al v. LabQ Clinical Diagnostics, LLC et al is an ongoing case where the court has granted an extension of time to complete discovery. This suggests active fact-finding and preparation phases are underway, potentially involving complex issues requiring additional time.

Stage

Active litigation

Timeline

2 events

Coverage

2 articles

Sources

1

Key Issues

  • Discovery extension
  • Fact-finding process
  • Case complexity
Advertisement

Case Timeline

2 events
info
Other April 15, 2026

1:22-cv-00751 United States of America et al v. LABQ Clinical Diagnostics, LLC et al.

In the case United States of America et al v. LabQ Clinical Diagnostics, LLC et al, a related event was recorded under a similar case number, indicating ongoing legal proceedings involving the same parties. This suggests the government is pursuing multiple actions or related claims against LabQ Clinical Diagnostics. Understanding these connections helps clarify the scope and seriousness of the legal challenges faced by the company.

info
Other April 14, 2026

1:22-cv-10313 United States of America et al v. LabQ Clinical Diagnostics, LLC et al

The court granted an extension of time for the parties in the case United States of America et al v. LabQ Clinical Diagnostics, LLC et al to complete the discovery process. This means both sides have more time to gather and exchange evidence before the trial. Extending discovery deadlines helps ensure that both parties can adequately prepare their cases.

Advertisement
newspaper

Press Coverage

2 articles